Zhejiang Xianju Pharmaceutical Co Ltd (002332) - Total Liabilities
Based on the latest financial reports, Zhejiang Xianju Pharmaceutical Co Ltd (002332) has total liabilities worth CN¥1.14 Billion CNY (≈ $167.22 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore long-term investment intensity of Zhejiang Xianju Pharmaceutical Co Ltd to see how much of total assets are deployed in long-term investments.
Zhejiang Xianju Pharmaceutical Co Ltd - Total Liabilities Trend (2006–2025)
This chart illustrates how Zhejiang Xianju Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Zhejiang Xianju Pharmaceutical Co Ltd assets under control.
Zhejiang Xianju Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Zhejiang Xianju Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Xpel Inc
NASDAQ:XPEL
|
USA | $113.84 Million |
|
Leon's Furniture Limited
TO:LNF
|
Canada | CA$1.22 Billion |
|
Anhui Guofeng Plastic Industry Co Ltd
SHE:000859
|
China | CN¥1.84 Billion |
|
OCI Co Ltd
KO:010060
|
Korea | ₩3.30 Trillion |
|
Kuangda Technology Group Co Ltd
SHE:002516
|
China | CN¥798.77 Million |
|
Blue Dart Express Limited
NSE:BLUEDART
|
India | Rs-17.77 Billion |
|
Everi Holdings Inc
NYSE:EVRI
|
USA | $1.94 Billion |
|
Anhui Shanying Paper Industry Co Ltd
SHG:600567
|
China | CN¥36.58 Billion |
Liability Composition Analysis (2006–2025)
This chart breaks down Zhejiang Xianju Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Zhejiang Xianju Pharmaceutical Co Ltd (002332) net asset quality to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.32 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.19 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.16 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zhejiang Xianju Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zhejiang Xianju Pharmaceutical Co Ltd (2006–2025)
The table below shows the annual total liabilities of Zhejiang Xianju Pharmaceutical Co Ltd from 2006 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥1.18 Billion ≈ $172.20 Million |
+5.88% |
| 2024-12-31 | CN¥1.11 Billion ≈ $162.64 Million |
-4.42% |
| 2023-12-31 | CN¥1.16 Billion ≈ $170.15 Million |
-5.52% |
| 2022-12-31 | CN¥1.23 Billion ≈ $180.09 Million |
-30.79% |
| 2021-12-31 | CN¥1.78 Billion ≈ $260.22 Million |
-21.17% |
| 2020-12-31 | CN¥2.26 Billion ≈ $330.11 Million |
-18.43% |
| 2019-12-31 | CN¥2.77 Billion ≈ $404.72 Million |
+1.20% |
| 2018-12-31 | CN¥2.73 Billion ≈ $399.92 Million |
-0.57% |
| 2017-12-31 | CN¥2.75 Billion ≈ $402.21 Million |
+98.64% |
| 2016-12-31 | CN¥1.38 Billion ≈ $202.48 Million |
+7.56% |
| 2015-12-31 | CN¥1.29 Billion ≈ $188.24 Million |
-18.30% |
| 2014-12-31 | CN¥1.57 Billion ≈ $230.42 Million |
+0.18% |
| 2013-12-31 | CN¥1.57 Billion ≈ $230.00 Million |
+26.72% |
| 2012-12-31 | CN¥1.24 Billion ≈ $181.51 Million |
+44.23% |
| 2011-12-31 | CN¥860.02 Million ≈ $125.85 Million |
+22.63% |
| 2010-12-31 | CN¥701.29 Million ≈ $102.62 Million |
-9.89% |
| 2009-12-31 | CN¥778.28 Million ≈ $113.89 Million |
+4.13% |
| 2008-12-31 | CN¥747.44 Million ≈ $109.37 Million |
+15.98% |
| 2007-12-31 | CN¥644.44 Million ≈ $94.30 Million |
+8.61% |
| 2006-12-31 | CN¥593.35 Million ≈ $86.83 Million |
-- |
About Zhejiang Xianju Pharmaceutical Co Ltd
Zhejiang Xianju Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of steroid raw materials and preparations in China and internationally. The company offers gynecological, anesthesia, respiratory, dermatology, generic drug, and other products; active pharmaceutical ingredients (API), such as corticosteroids, sex hormone, progestero… Read more